DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice
DENVER, Oct. 20, 2026 /PRNewswire/ -- DaVita today issued the following statement in response to the U.S. Department of Health and Human Services' Kidney Care National Plan and related remarks regarding the future of kidney care: DaVita shares the Administration's urgency to accelerate...
Covered in this story
Analyst targets on DaVita
- TD Cowen: $184 → $220 by Aug 2027 · Buy via Yahoo Finance
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $DVA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on DaVita →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.